This item is authorised by the following title:
Amendment Statement of Principles concerning Guillain-Barre syndrome (Reasonable Hypothesis) (No. 74 of 2022)
Amendment Statement of Principles concerning Guillain-Barre syndrome (Reasonable Hypothesis) (No. 57 of 2021)